The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(3,4-dichlorophenyl)-N-((3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acrylamide ID: ALA3805752
PubChem CID: 127052625
Max Phase: Preclinical
Molecular Formula: C15H17Cl2NO5
Molecular Weight: 362.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/c1ccc(Cl)c(Cl)c1)N[C@H]1CO[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C15H17Cl2NO5/c16-9-3-1-8(5-10(9)17)2-4-13(20)18-11-7-23-12(6-19)15(22)14(11)21/h1-5,11-12,14-15,19,21-22H,6-7H2,(H,18,20)/b4-2+/t11-,12+,14+,15+/m0/s1
Standard InChI Key: MDRADRFVHCEAIO-ALMBQQNPSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
2.6003 -1.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5973 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5956 2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4990 -0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8003 -1.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0994 -0.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3984 -1.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3985 -2.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0995 -3.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8004 -2.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0995 -4.9387 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.4377 -3.5886 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8969 0.4545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
3 2 1 0
4 3 1 0
5 4 1 0
6 5 1 0
7 6 1 0
2 7 1 0
7 8 1 1
6 9 1 6
5 10 1 1
11 10 1 0
1 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
19 21 1 0
18 22 1 0
12 23 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.21Molecular Weight (Monoisotopic): 361.0484AlogP: 0.60#Rotatable Bonds: 4Polar Surface Area: 99.02Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.92CX Basic pKa: ┄CX LogP: 0.71CX LogD: 0.71Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: 0.43
References 1. Lin H, Zeng J, Xie R, Schulz MJ, Tedesco R, Qu J, Erhard KF, Mack JF, Raha K, Rendina AR, Szewczuk LM, Kratz PM, Jurewicz AJ, Cecconie T, Martens S, McDevitt PJ, Martin JD, Chen SB, Jiang Y, Nickels L, Schwartz BJ, Smallwood A, Zhao B, Campobasso N, Qian Y, Briand J, Rominger CM, Oleykowski C, Hardwicke MA, Luengo JI.. (2016) Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors., 7 (3): [PMID:26985301 ] [10.1021/acsmedchemlett.5b00214 ]